Placental Expression of Cell Biomarkers in Negative, Vaccinated, and Positive Pregnant Women

Constantin Condac,Ludmila Lozneanu,Daniela Roxana Matasariu,Alexandra Ursache,Iuliana Elena Bujor,Maria Elena Niță,Vasile Lucian Boiculese,Victoria Bîrluțiu
DOI: https://doi.org/10.3390/jcm13185546
IF: 3.9
2024-09-20
Journal of Clinical Medicine
Abstract:Background: We investigated the expression of inflammation, placental development, and function markers, including cluster of differentiation 44 (CD44), osteopontin (OPN), and cyclooxygenase-2 (COX-2), to shed light on the controversy regarding the impact of the COVID-19 epidemic on fetal development and pregnancy outcomes. Methods: We immunohistochemically analyzed placental tissue from 170 patients (65 COVID-positive and unvaccinated women; 35 Pfeizer-vaccinated and COVID-negative women; and 70 COVID-negative and unvaccinated women, without any other associated pathology) for particularities in the expression of these three molecules. Results: CD44 expression was highest in COVID-negative and unvaccinated women, moderate in COVID-positive cases, and lowest in vaccinated and COVID-negative women. OPN expression was highest in COVID-negative and Pfeizer-vaccinated cases, moderate in COVID-negative and unvaccinated cases, and lowest in COVID-positive cases. COX-2 expression was increased in COVID-negative and unvaccinated women, modestly elevated in COVID-positive and unvaccinated cases, and lowest in vaccinated cases. Conclusions: These findings reflected an alteration in the placental structure and consequent function due to altered expression of the three studied molecules.
medicine, general & internal
What problem does this paper attempt to address?